Dr. Reddy's Laboratories (DRREDDY) — Corporate Action

Dr. Reddy's Laboratories disclosed a tax notice from the Hyderabad Income Tax office regarding potential reassessment of FY 2019-20 income linked to the 2019 merger of Dr. Reddy's Holding Limited, with a proposed demand of ₹2395.82 crores. The company states there is no material impact on financials or operations and is reviewing the notice.

📄 View Original Announcement (PDF)

📊 Stock Analysis — DRREDDY ✨ Ask AI About This

About Dr. Reddy's Laboratories Limited (DRREDDY)

Healthcare · Pharmaceuticals & Biotechnology · Listed on NSE

Market Cap: ₹1,11,568.6 Cr P/E: 20.0 ROE: 16.6% ROCE: 19.7%

View full DRREDDY stock details →

📡 Get AI alerts when DRREDDY files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track DRREDDY — Free

💡 Ask AI about this filing

"How does this corporate action affect Dr. Reddy's Laboratories Limited's outlook?" "What did Dr. Reddy's Laboratories Limited announce on 5 April 2025?" "Is this positive or negative for DRREDDY?"

Ask AI Free →

📊 More DRREDDY filings

See all DRREDDY filings →

🔥 Also filed on 5 April 2025

TRENT Trent Limited Financial Results WIPRO Wipro Limited Corporate Action DELHIVERY Delhivery Limited Board Meeting DELHIVERY Delhivery Limited Board Meeting IDEA Vodafone Idea Limited Buyback / Redemption

View all today's announcements →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when DRREDDY files new disclosures

Track DRREDDY filings, board meetings, and corporate actions. Free email alerts at 5 PM.